EASI:ARCA-Amplify ETF Trust

ETF | Allocation--50% to 70% Equity | NYSE Arca

Last Closing

USD 23.7602

Change

-0.27 (-1.12)%

Market Cap

USD 2.38M

Volume

1.73K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Inception Date: 13/06/2018

Primary Benchmark: EASI Tactical Growth Index TR USD

Primary Index:

Gross Expense Ratio: %

Management Expense Ratio: 0.75 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
GMED Globus Medical 2.82 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-10-17 )

Largest Industry Peers for Allocation--50% to 70% Equity

Symbol Name Mer Price(Change) Market Cap
AOR iShares Core Growth Allocation.. 0.18 %

+0.34 (+0.61%)

USD 2.00B
RLY SPDR® SSgA Multi-Asset Real R.. 0.22 %

+0.23 (+0.84%)

USD 0.54B
GAL SPDR® SSgA Global Allocation .. 0.09 %

+0.33 (+0.77%)

USD 0.24B
OCIO ClearShares OCIO ETF 0.54 %

+0.22 (+0.69%)

USD 0.13B

ETFs Containing EASI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Allocation--50% to 70% Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A F
Risk Adjusted Return N/A N/A N/A N/A F
Market Capitalization 2.38M 17% F 2% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.